Results:
NEJM
STM

What is new in iPrEx?

A celebration of life

Jeff McConnell


• • • • • •


iPrEx OLE announces final study visit

The last participation took place in Lima Peru


• • • • • •


Circumcision effectively reduces the risk of HIV

ANRS Project in Orange Farm


• • • • • •


HPTN 073 PrEP Demonstration Project

Enrolling in three US cities


• • • • • •


IAS 2013

iPrEX Participants interested in continuing HIV PrEP


• • • • • •


PrEP is Safe and Effective in Injection Drug Users

We must move quickly to implement demonstration projects in IDU


• • • • • •


A new PrEP Study

Recruiting participants in England


• • • • • •


VOICE Results

Confirm that PrEP is Effective...


• • • • • •


Pilot demostration and Evaluation Project HIV-1

The Partners Demonstration Project


• • • • • •


ATN launches the PrEPare study

14 sites in the US are making part


• • • • • •


ANRS-IPERGAY study should be discontinued

prevention research in France is in disarray


• • • • • •


The Anrs decides to continue its Ipergay trial

And creates a new working group on HIV prevention


• • • • • •


Truvada aprobada en Ecuador

Para tratamiento de infección por VIH


• • • • • •


San Francisco AIDS Foundation (SFAF) launched a PrEP Information Site

To provide community information


• • • • • •


SFDPH launched Demo Project of PrEP

To evaluate the delivery of PrEP in STD clinics


• • • • • •


PrEP Interim Guidance for PrEP in Sexually Active Heterosexual Adults

CDC released today


• • • • • •


WHO issues first PrEP guidance

After FDA approved Truvada for PrEP


• • • • • •


HPTN Launches NEXT-PrEP Trial

The study will evaluate Maraviroc


• • • • • •


Truvada approved for HIV prevention

FDA announced today


• • • • • •


The iPrEx Study Closed Enrollment in OLE

Follow up will end in February of 2014


• • • • • •


ad-hoc-PrEP Group Southern African guidelines

For the safe use of pre-exposure prophylaxis in MSM


• • • • • •


BBC News: Interview with Robert Grant.

PrEP and its potential after FDA Advisory Committee Meeting


• • • • • •


AVDAC Recommends FTC/TDF

For the prevention of HIV infection in adults as PrEP


• • • • • •


iPrEx and the Supplemental New Drug Application of Truvada for PrEP

Questions and Answers


• • • • • •


AIDS Advocates Support FDA Approval of PrEP

Urgent Need of New HIV Prevention Tools to End AIDS


• • • • • •


UC will test HIV prevention pills

11.8 million dollars granted


• • • • • •


FDA finalizes Audits at Global iPrEx in South America

No critical issues in the implementation of the study.


• • • • • •


FDA performs visit inspection to the Ecuador site

To check the conduction of the Global iPrEx


• • • • • •


Truvada Priority Review

U.S.Food and Drug Administration (FDA)


• • • • • •


Launch of first pre-HIV exposure prevention trial for gay men in Europe

IPERGAY is a French ANRS initiative


• • • • • •


FDA asked to approve NEW HIV PREVENTION METHOD

Gilead submitted supplemental New Drug Application (sNDA)


• • • • • •


Bob Grant
People who Mattered in 2011

TIME Magazine


• • • • • •


VOICE DSMB Recommends Stopping Tenofovir Gel Arm

NIAID has made a public announcement on November 25, 2011


• • • • • •


iPrEx OLE: 279 additional participants

CDC Project T will Join the study


• • • • • •


Unblinding iPrEx

iPrEx study sites have been unblinding participants since June of 2011


• • • • • •


PrEP Demonstration Projects about to be Launched

San Francisco will be the first city in the United States


• • • • • •


6th IAS Conference

New data confirm eficacy and safety of PrEP


• • • • • •


iPrEx OLE begins at 11 sites in six countries

iPrEx OLE to Build on News that PrEP Slows HIV Infections


• • • • • •


News on Partners PrEP and CDC Botswana

Studies detailing the safety and effectiveness of PrEP


• • • • • •


The FACTS 001 tenofovir gel study

Follow up to CAPRISA 004


• • • • • •


Intermittent PrEP

HPTN 067 about to be launched


• • • • • •


30 years into the epidemic

Will this be the end of AIDS?


• • • • • •


News on HPTN 052

Another HIV Prevention Trial Shows Success


• • • • • •


News on FEM-PrEP

FEM-PrEP trial is stopped by the IDMC

Link to FHI/FEM-PrEP


• • • • • •


CROI 2011

iPrEx presented new data in the conference in Boston

iPrEx CROI release


• • • • • •


US Centers for Disease Control and Prevention (CDC)

Interim Guidance: Pre-exposure prophylaxis (PrEP) for the prevention of HIV infection in men who have sex with men



Global
Media
Results

iPrEx, or Pre-Exposure Prophylaxis Initiative is a clinical trial aimed at determining whether two antiretroviral (ARV) medications used to treat HIV/AIDS help prevent HIV acquisition in HIV-uninfected people at high risk of infection.

 

 

 

 

© iPrEx 2011